KMT2A and acute myeloid leukemia: In acute myeloid leukemia (AML), initiating mutations (such as the commonly occurring AF9-MLL translocation) dysregulate stem cell fate decisions in HSPCs, generating pre-leukemic stem cells (pre-LSCs) [2].